SCHEMBL20213685

SCHEMBL20213685

NC1=C2C(=O)N=CN=C2N=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8324914 0.75
SCHEMBL1923502 0.75
SCHEMBL19434573 0.64 PDE1B (0.32)
SCHEMBL4934278 0.58
SCHEMBL73936 0.55
SCHEMBL22194798 0.55
SCHEMBL5821191 0.55
SCHEMBL10751007 0.55
SCHEMBL8621147 0.55
SCHEMBL11414515 0.54

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11091490-B2 3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors MEDIZINISCHE UNIVERSITÄT INNSBRUCK (AT) 2021-08-17 US disclosed
US-11091490-B2 3-amino-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-ones as cyclin dependent kinase inhibitors MEDIZINISCHE UNIVERSITÄT INNSBRUCK (AT) 2021-08-17 US disclosed
US-20200247809-A1 3-AMINO-1,5-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONES AS CYCLIN DEPENDENT KINASE INHIBITORS ONCOTYROL CENTER FOR PERSONALIZED CANCER MEDICINE GMBH (AT) 2020-08-06 US disclosed
US-20200247809-A1 3-AMINO-1,5-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONES AS CYCLIN DEPENDENT KINASE INHIBITORS ONCOTYROL CENTER FOR PERSONALIZED CANCER MEDICINE GMBH (AT) 2020-08-06 US disclosed
EP-3548488-A1 3-AMINO-1,5-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONES AS CYCLIN DEPENDENT KINASE INHIBITORS Oncotyrol Center for Personalized Cancer Medicine GmbH (AT) 2019-10-09 EP disclosed
EP-3548488-A1 3-AMINO-1,5-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONES AS CYCLIN DEPENDENT KINASE INHIBITORS Oncotyrol Center for Personalized Cancer Medicine GmbH (AT) 2019-10-09 EP disclosed
WO-2018099952-A1 3-AMINO-1,5-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONES AS CYCLIN DEPENDENT KINASE INHIBITORS ONCOTYROL CENTER FOR PERSONALIZED CANCER MEDICINE GMBH (AT) 2018-06-07 WO disclosed
WO-2018099952-A1 3-AMINO-1,5-DIHYDRO-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONES AS CYCLIN DEPENDENT KINASE INHIBITORS ONCOTYROL CENTER FOR PERSONALIZED CANCER MEDICINE GMBH (AT) 2018-06-07 WO disclosed